These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3484995)

  • 21. The antipyretic effects of centrally administered vasopressin at different ambient temperatures.
    Wilkinson MF; Kasting NW
    Brain Res; 1987 Jul; 415(2):275-80. PubMed ID: 3496937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diazepam attenuation of somatostatin-induced motor disturbances and neurotoxicity.
    Balaban CD; Roskams AJ; Severs WB
    Brain Res; 1988 Aug; 458(1):91-6. PubMed ID: 2905196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of centrally injected AVP on heart rate, core temperature, and behavior in rats.
    Diamant M; De Wied D
    Am J Physiol; 1993 Jan; 264(1 Pt 2):R51-61. PubMed ID: 8430886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arginine-vasopressin and lysine-vasopressin have different effects on spontaneous behaviour of rats.
    Tendis S; Klingberg F; Schaeker W
    Biomed Biochim Acta; 1987; 46(10):719-25. PubMed ID: 3446200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus.
    Qadri F; Culman J; Veltmar A; Maas K; Rascher W; Unger T
    J Pharmacol Exp Ther; 1993 Nov; 267(2):567-74. PubMed ID: 8246129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central modulation of immunoreactive corticotropin-releasing factor secretion by arginine vasopressin.
    Plotsky PM; Bruhn TO; Vale W
    Endocrinology; 1984 Oct; 115(4):1639-41. PubMed ID: 6332731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
    Croiset G; De Wied D
    Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic corticotropin-releasing hormone and vasopressin regulate corticosteroid receptors in rat hippocampus and anterior pituitary.
    Hügin-Flores ME; Steimer T; Schulz P; Vallotton MB; Aubert ML
    Brain Res; 2003 Jun; 976(2):159-70. PubMed ID: 12763250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central vasopressin pretreatment sensitizes phosphoinositol hydrolysis in the rat septum.
    Lebrun CJ; Gruber MG; Meister M; Unger T
    Brain Res; 1990 Oct; 531(1-2):167-72. PubMed ID: 1963099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of chronic icv infusion of vasopressin on sleep-waking cycle of rats.
    Arnauld E; Bibene V; Meynard J; Rodriguez F; Vincent JD
    Am J Physiol; 1989 Mar; 256(3 Pt 2):R674-84. PubMed ID: 2923256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory action of leumorphin on vasopressin secretion in conscious rats.
    Yamada T; Nakao K; Itoh H; Morii N; Shiono S; Sakamoto M; Sugawara A; Saito Y; Mukoyama M; Arai H
    Endocrinology; 1988 Mar; 122(3):985-90. PubMed ID: 3342763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Centrally administered parathyroid hormone (PTH)-related protein(1-34) but not PTH(1-34) stimulates arginine-vasopressin secretion and its messenger ribonucleic acid expression in supraoptic nucleus of the conscious rats.
    Yamamoto S; Morimoto I; Zeki K; Ueta Y; Yamashita H; Kannan H; Eto S
    Endocrinology; 1998 Jan; 139(1):383-8. PubMed ID: 9421437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of intracerebroventricular injections of morphine on vasopressin release in the rat.
    Aziz LA; Forsling ML; Woolf CJ
    J Physiol; 1981 Feb; 311():401-9. PubMed ID: 7264975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasopressin-induced motor disturbances: localization of a sensitive forebrain site in the rat.
    Naylor AM; Ruwe WD; Burnard DM; McNeely PD; Turner SL; Pittman QJ; Veale WL
    Brain Res; 1985 Dec; 361(1-2):242-6. PubMed ID: 3910167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arginine vasopressin prevents against Abeta(25-35)-induced impairment of spatial learning and memory in rats.
    Pan YF; Chen XR; Wu MN; Ma CG; Qi JS
    Horm Behav; 2010 Apr; 57(4-5):448-54. PubMed ID: 20138885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mediation of the stress-induced prolactin release by hypothalamic histaminergic neurons and the possible involvement of vasopressin in this response.
    Kjaer A; Knigge U; Olsen L; Vilhardt H; Warberg J
    Endocrinology; 1991 Jan; 128(1):103-10. PubMed ID: 1986913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sympathetic activation following central vasopressin receptor stimulation in conscious rats.
    Unger T; Rohmeiss P; Becker H; Ganten D; Lang RE; Petty M
    J Hypertens Suppl; 1984 Dec; 2(3):S25-7. PubMed ID: 6100738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arginine8-vasopressin potentiates the motor incoordinating effects of pentobarbital.
    Marchese A; Mihic SJ; Wu PH; Kalant H
    Eur J Pharmacol; 1991 Sep; 202(3):341-5. PubMed ID: 1748156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of central pressor effect of AVP in SHR and WKY rats by intracranial N(G)-nitro-L-arginine.
    Paczwa P; Budzikowski AS; Szczepańska-Sadowska E
    Brain Res; 1997 Feb; 748(1-2):51-61. PubMed ID: 9067444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible involvement of endogenous opioid peptides in the inhibition of arginine vasopressin release by gamma-aminobutyric acid in conscious rats.
    Otake K; Kondo K; Oiso Y
    Neuroendocrinology; 1991 Aug; 54(2):170-4. PubMed ID: 1766553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.